ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates - Wikidata - wikimedia - TriplyDB

ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates

ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates

http://www.wikidata.org/entity/Q34230813

about

A balancing act: efflux/influx in mycobacterial drug resistance Mechanism of thioamide drug action against tuberculosis and leprosy Strategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosis Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides Triclosan Derivatives: Towards Potent Inhibitors of Drug-Sensitive and Drug-ResistantMycobacterium tuberculosis Towards a new tuberculosis drug: pyridomycin - nature's isoniazid Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria Genome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South Africa Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa Elucidating emergence and transmission of multidrug-resistant tuberculosis in treatment experienced patients by whole genome sequencing High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition Application of quantitative second-line drug susceptibility testing at a multidrug-resistant tuberculosis hospital in Tanzania.Compounds for use in the treatment of mycobacterial infections: a patent evaluation (WO2014049107A1).Accurate and effective multidrug-resistant Mycobacterium tuberculosis detection method using gap-filling ligation coupled with high-resolution capillary electrophoresis-based single strand conformation polymorphism.EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide.New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa Rapid in vivo detection of isoniazid-sensitive Mycobacterium tuberculosis by breath test Extensively Drug-Resistant Tuberculosis: A Sign of the Times and an Impetus for Antimicrobial Discovery.Biological evaluation of potent triclosan-derived inhibitors of the enoyl-acyl carrier protein reductase InhA in drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases.Platforms for antibiotic discovery.Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance.Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis Comparative analysis of mycobacterial NADH pyrophosphatase isoforms reveals a novel mechanism for isoniazid and ethionamide inactivation Pharmacogenomic strategies against resistance development in microbial infections.Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.Virtually Designed Triclosan-Based Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis and of Plasmodium falciparum.[Molecular diagnosis of Mycobacterium tuberculosis complex resistant to isoniazid and rifampicin in Burkina Faso]Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

P2860

Q24644870-69204298-84C6-48A6-9290-E9CF93D7047C Q24676495-0690DB54-82BE-4B54-8D74-6BA20D637414 Q27003186-62056116-B8BB-4C06-9515-AB6B47A76AD7 Q27647576-0F0C6BC4-BF86-41BD-96C4-BB2EFC4779EB Q27653366-290A2EF5-05E5-44FB-A1CE-5AB6AC7BB7DE Q27673316-7A70DA3A-D484-4E5A-8A07-0D9F73C833EA Q28389409-2E75B2AA-1F63-4A2C-9C52-B200B11488F8 Q28471774-7B99D533-EDB9-47EF-A107-5ABEAE34EEAD Q28475985-E56327FE-2B1E-48C7-A729-F636634E28A8 Q28486213-9FF0B48D-BD49-490D-AE1C-5F91B097A26F Q28487401-A50A2CDF-14C8-4320-B13C-C6B459C03605 Q28535594-D0DE67F4-3367-4642-B799-0E682397FCCE Q28536869-EE84CA95-6402-47D6-AB87-F66C2AAA3402 Q28547703-F2EDE330-A8FB-4DA4-8A28-FF639A586104 Q28550401-2B3C4AD0-ECA1-4B30-9EDF-0EAC41561143 Q28659734-7950C043-473B-4672-9291-822804206BE4 Q30415943-644CB164-4090-494E-A3E2-642CED08A08A Q30907456-EB1BC70C-FC4A-4723-914F-426529F08DFB Q33576611-B95A2455-9F62-4019-B341-1B20721E1D3D Q33599760-1A5242E1-9E92-4A7C-A3BB-E8F4B6AE629B Q33600161-ECC9F52F-24BA-40D5-A0BB-8B70D4A8A0E8 Q33676299-3193CBC0-3A76-4230-84A5-5FE77EF86BC5 Q33756724-D900181E-0F66-40D6-B3AA-6FABE35ED335 Q34278222-7CDCB652-EE0D-40E9-8660-83169D56F4C6 Q34410451-E875DFA1-DBA4-4604-B117-AB2384779F41 Q34421869-58B27B52-AD81-4DCD-AB7E-66C3C2B14C01 Q34483621-AEA09793-8465-492C-BD3B-8FD0094AE41C Q34551145-978A7B5F-335C-41F5-9526-C3B8054A0A8F Q34694926-3F2A3A9D-E901-4FD2-9137-8E1FCF2FAD04 Q35073562-C3CA7601-98E9-418D-AFF7-DBF46484758B Q35689424-20B30F68-A320-4BB9-BFE0-5CE3ECCD6026 Q35769769-E9BB9AAC-BA17-4B3F-B4AB-B22A8A357BE0 Q35785222-CA072B1B-EC1D-4395-8300-B4FF3F4BC283 Q35947438-A8704594-34D0-4719-90DD-58711E33A7C1 Q36057012-9F8FDC6B-EDC5-4176-9A15-9D1109889884 Q36094825-E79CC6E7-5248-4B13-8931-D1C1C0865561 Q36126434-1E9F4AEB-E31D-44D2-A946-EE78A26767D8 Q36290565-EED786CC-3AB9-48CA-85F5-81E78B79D4C9 Q36844683-2A40E356-DB18-4D52-AD7C-41AA4CC593E8 Q36960077-383E38BB-342F-4D95-A31C-66DC95265287

P2860

ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates

http://www.wikidata.org/entity/Q34230813

description

2003 nî lūn-bûn

@nan

2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@ast

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@en

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@nl

type

label

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@ast

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@en

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@nl

prefLabel

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@ast

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@en

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@nl

P1433

Q34230813-3CDFC133-FCCE-495B-83F7-2EEB617BF73C

P1476

Q34230813-5B5FAE80-A6B9-4E9B-9402-277A0708D0D5

P2093

Q34230813-23AE041A-5C36-4FB7-A248-FE28EE0ECD2B

Q34230813-383DB2EB-B1A9-4F7A-A53C-13FC292AFE68

Q34230813-4517CE79-74C6-4BC1-9EEF-3BDC54B79FCC

Q34230813-714FBF07-70B2-4131-9AB4-23EE2FE9E448

Q34230813-ABCD731B-8751-40BE-90D4-D7D3881CC47D

P2860

Q34230813-00841ABB-E9C8-4CE9-B485-7EB722741D05

Q34230813-3F6DB07F-FC01-494F-93FF-0F3F98E20E02

Q34230813-4ACEF161-539D-4248-B76F-4429431DC8E2

Q34230813-5ABEE63B-F420-4822-B9BD-C033DF7C7DC6

Q34230813-5DFB8CD6-3799-40E4-9F40-11C260A502C9

Q34230813-77D55022-17AC-4DD9-8A4C-654AB93F53C7

Q34230813-78F0C99A-45C7-4E72-9A06-586B26D3446F

Q34230813-7DDAD4B1-AFAE-4F9D-AC5F-1A42937E79FA

Q34230813-7E656CC0-69C4-4862-B9BB-A5F672620833

Q34230813-7ED99FEF-F72A-464B-AF1D-4E332DC03E57

P304

Q34230813-5C4BC456-24A8-437D-B613-3FF6186749C1

P31

Q34230813-8773D569-801B-416E-84F8-37F9AA3DEBE3

P356

Q34230813-3AE221DE-4E8B-4CCA-8E19-BA7050BDDA9F

P407

Q34230813-66B0EE07-3EE9-4672-B887-E31436A4A88C

P433

Q34230813-F251F7BB-A121-4E65-A5E6-B8B1422A61E7

P478

Q34230813-B32C9B85-158B-48AA-B65B-76F3165DB6F1

P577

Q34230813-31C771D6-9ADB-469F-901C-8EE1F5718344

P698

Q34230813-6D16F446-C8AB-483C-B95D-54CF975D486F

P921

Q34230813-2A7AEE09-D061-429C-B1B4-57D759DBEFB1

P932

Q34230813-B6E15B5A-2731-4244-A564-63276D768211

P356

AAC.47.12.3799-3805.2003

P1433

Antimicrobial Agents and Chemotherapy

P1476

ethA, inhA, and katG loci of e ...... acterium tuberculosis isolates

@en

P2093

Beverly Metchock

http://www.w3.org/2001/XMLSchema#string

David Sikes

http://www.w3.org/2001/XMLSchema#string

Glenn P Morlock

http://www.w3.org/2001/XMLSchema#string

Jack T Crawford

http://www.w3.org/2001/XMLSchema#string

Robert C Cooksey

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis

Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis

Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus

Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis

Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis

Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay

Activation of the pro-drug ethionamide is regulated in mycobacteria

The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis

inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis

Phenotypic characterization of pncA mutants of Mycobacterium tuberculosis.

P304

3799-3805

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.47.12.3799-3805.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14638486

http://www.w3.org/2001/XMLSchema#string

P921

Mycobacterium tuberculosis

P932

296216

http://www.w3.org/2001/XMLSchema#string